Literature DB >> 25421682

P53 tumor suppression network in cancer epigenetics.

Alok Mishra1, Daniel J Brat, Mukesh Verma.   

Abstract

The tumor suppressor p53 is one of the most complex and widely studied genes in cancer biology. In spite of the vast on literature the transcriptional regulation of p53, aspects of its especially epigenetic regulation are not completely understood. This chapter presents a concise overview of p53-related epigenetic events involved in oncogenesis and tumor suppression. We limit the scope to epigenetic modifications of the p53 promoter per se as well as its well-established downstream targets. The indirect role of p53 affecting the epigenetic machinery of cancer cells via specific proteins and transcription factors is discussed. Current concepts of p53-related cancer epigenetics offer myriad avenues for cancer therapies. Challenges in the field are also discussed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25421682     DOI: 10.1007/978-1-4939-1804-1_31

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

Review 1.  Current status in cancer cell reprogramming and its clinical implications.

Authors:  Kenan Izgi; Halit Canatan; Banu Iskender
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

2.  Genome-wide association studies and epigenome-wide association studies go together in cancer control.

Authors:  Mukesh Verma
Journal:  Future Oncol       Date:  2016-04-15       Impact factor: 3.404

3.  The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53.

Authors:  Wen-Fang Li; Arin Herkilini; Yu Tang; Ping Huang; Guan-Bin Song; Makoto Miyagishi; Vivi Kasim; Shou-Rong Wu
Journal:  Acta Pharmacol Sin       Date:  2021-02-01       Impact factor: 6.150

Review 4.  Regulating tumor suppressor genes: post-translational modifications.

Authors:  Ling Chen; Shuang Liu; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2020-06-10

5.  LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270.

Authors:  Aimei Zou; Xingli Liu; Zongjiong Mai; Junke Zhang; Zhuohuan Liu; Qilu Huang; Aibing Wu; Chenyu Zhou
Journal:  Mol Ther Nucleic Acids       Date:  2019-06-15       Impact factor: 8.886

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.